|
JDP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.790620E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.28329999644117E-08 |
| Normal-vs-Stage2 |
3.235800E-01 |
| Normal-vs-Stage3 |
5.398200E-01 |
| Normal-vs-Stage4 |
4.570000E-01 |
| Stage1-vs-Stage2 |
4.441600E-02 |
| Stage1-vs-Stage3 |
3.54650000000678E-05 |
| Stage1-vs-Stage4 |
2.292400E-01 |
| Stage2-vs-Stage3 |
5.535800E-01 |
| Stage2-vs-Stage4 |
9.091000E-01 |
| Stage3-vs-Stage4 |
6.134000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.902500E-03 |
| Normal-vs-AfricanAmerican |
1.598150E-03 |
| Normal-vs-Asian |
5.515800E-01 |
| Caucasian-vs-AfricanAmerican |
2.010400E-02 |
| Caucasian-vs-Asian |
9.999200E-01 |
| AfricanAmerican-vs-Asian |
3.715400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.742600E-03 |
| Normal-vs-Female |
8.32330000000159E-05 |
| Male-vs-Female |
1.369640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.012400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.046600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.297800E-02 |
| Normal-vs-Age(81-100Yrs) |
9.819600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.944600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.069200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.341170E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.141600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.554270E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.200000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.78729999999706E-05 |
| Normal-vs-Grade 2 |
1.31620000010102E-07 |
| Normal-vs-Grade 3 |
3.254800E-01 |
| Normal-vs-Grade 4 |
4.634400E-01 |
| Grade 1-vs-Grade 2 |
1.894300E-02 |
| Grade 1-vs-Grade 3 |
7.47550000013142E-07 |
| Grade 1-vs-Grade 4 |
4.115400E-03 |
| Grade 2-vs-Grade 3 |
1.85075999999951E-05 |
| Grade 2-vs-Grade 4 |
2.821000E-01 |
| Grade 3-vs-Grade 4 |
6.612600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.29160004492502E-09 |
| Normal-vs-ccB subtype |
8.465400E-01 |
| ccA subtype-vs-ccB subtype |
6.28120000456533E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.066400E-02 |
| Normal-vs-N1 |
6.042200E-01 |
| N0-vs-N1 |
1.385770E-01 |
|
|
